Back to search
Paranoid Delusions
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Paranoid Delusions trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Paranoid Delusions trials you may qualify forThe goal of this clinical trial is to learn whether learning and belief updating change in response to the treatment of persecutory delusions, in individuals wi…
The aim of this study is to investigate the role of the immune system in psychotic symptoms and their response to treatment. The investigators will collect bloo…
The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizop…
Hallucinations or delusions that occur for the first time in older people with no acute medical problems or mood symptoms may be related to impending dementia.…
Rationale: Ethnic minorities and asylumseekers have a two- to three-times increased risk of psychosis compared to people from their host country. Among patients…
The goal of this clinical trial is to compare the efficacy of combined REHACOP + MCT alone in persons with nonaffective psychotic disorder in terms of recovery.…
Over 60% of Veterans with serious mental illness have a service-connected disability that impairs their ability to work, go to school, and/or have successful pe…
This study aims to provide an evidence-based shared decision making intervention for antipsychotic medications, the Antipsychotic Medication Decision Aid (APM-D…
Recovery-oriented care is an imperative for the VA, particularly in mental health programming for Veterans with serious mental illness (SMI). Collaborative deci…